Saturday, December 20, 2025

‘More of an Instinct’: Trump Explains How He’ll Decide Which Companies Get Tariff Exemptions

President Donald Trump revealed Wednesday he may grant exemptions to certain companies hurt by his sweeping tariffs based primarily on his “instinct” rather than established economic analysis.

“You almost can’t take a pencil to paper. It’s really more of an instinct than anything else,” Trump told reporters during a press conference with Treasury Secretary Scott Bessent. “Some companies, through no fault of their own, they happen to be in an industry that is more affected by these things than others.”

The vague process, without established guidelines or oversight, creates a situation where companies may need to appeal directly to the administration for relief. Trump’s statement that “you have to be able to show a little flexibility, and I’m able to do that” suggests a personalized approach to exemptions that could advantage businesses with stronger connections to the White House.

The administration has already carved out exemptions for approximately $644 billion in imports following Trump’s “Liberation Day” tariff announcements, which imposed a 10% universal tariff on imported goods plus higher “reciprocal” tariffs targeting China and European Union countries. 

The Wall Street Journal reports $185 billion of these exemptions benefit goods from Canada and Mexico, though these nations face other trade restrictions.

Trump’s approach to trade policy has introduced significant uncertainty for businesses. His metaphorical explanation about needing to go “under the wall, around the wall or over the wall” when obstacles appear did little to clarify his decision-making process, instead highlighting the unpredictable nature of the exemption system.

Pharmaceutical companies, temporarily exempted while undergoing a Section 232 investigation, may soon face what Trump described as “a major tariff” despite the ongoing review. At a National Republican Congressional Committee dinner Tuesday night, Trump indicated pharmaceutical tariffs would be announced “very soon,” suggesting the investigation’s outcome may already be predetermined.

Related: Kimbal, Elon Musk’s Brother, Calls Out Trump For “Permanent Tax” On US Consumer


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Soma Gold: Q3 Earnings Impacted By Labour Strike

Thesis Gold: The Multi-Billion Dollar Lawyers-Ranch PFS

Why Canada Has So Few Projects That Can Be Built Before 2030 | Dan Wilton – First Mining

Recommended

Northern Superior Shareholders Set To Receive Shares Of ONGold Resources Friday

Goliath Resources Sees Rob McEwen Increase Ownership Interest

Related News

Citadel Securities Reportedly Going Into Crypto In A Trump-Endorsed Boom Era

Ken Griffin’s Citadel Securities is reportedly preparing to enter the cryptocurrency market as a liquidity...

Tuesday, February 25, 2025, 12:05:00 PM

Trump Unleashes 25% Tariff On EU: “They’re Formed To Screw The US”

In another episode on tariff threats, President Donald Trump has announced plans to impose sweeping...

Thursday, February 27, 2025, 09:32:00 AM

‘Time to Make a Deal’: Trump Threatens New Trade Restrictions on Russia Over Ukraine War

President Donald Trump has warned Russia of severe economic consequences if the ongoing war in...

Thursday, January 23, 2025, 03:47:00 PM

Despite Warmer Relations, US Envoy Says Canada Tariffs Likely to Persist

The United States has “moved beyond” President Donald Trump’s repeated suggestions that Canada become the...

Tuesday, May 13, 2025, 09:13:00 AM

Trump’s Mugshot Has Already Made Him Millions In Campaign Funding

The Trump campaign has come a long way from its NFT days. Since former President...

Thursday, August 31, 2023, 10:34:32 AM